PortfoliosLab logoPortfoliosLab logo
XDG3.DE vs. CIB0.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

XDG3.DE vs. CIB0.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

XDG3.DE vs. CIB0.DE - Yearly Performance Comparison


2026 (YTD)202520242023
XDG3.DE
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C
-3.31%1.47%9.58%2.52%
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
-9.78%-10.00%5.16%-3.14%

Returns By Period

In the year-to-date period, XDG3.DE achieves a -3.31% return, which is significantly higher than CIB0.DE's -9.78% return.


XDG3.DE

1D
1.21%
1M
-4.31%
YTD
-3.31%
6M
2.47%
1Y
-2.74%
3Y*
3.65%
5Y*
10Y*

CIB0.DE

1D
1.37%
1M
-8.85%
YTD
-9.78%
6M
-3.29%
1Y
-11.01%
3Y*
-6.52%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XDG3.DE vs. CIB0.DE - Expense Ratio Comparison

XDG3.DE has a 0.35% expense ratio, which is lower than CIB0.DE's 0.55% expense ratio.


Return for Risk

XDG3.DE vs. CIB0.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XDG3.DE
XDG3.DE Risk / Return Rank: 99
Overall Rank
XDG3.DE Sharpe Ratio Rank: 99
Sharpe Ratio Rank
XDG3.DE Sortino Ratio Rank: 88
Sortino Ratio Rank
XDG3.DE Omega Ratio Rank: 88
Omega Ratio Rank
XDG3.DE Calmar Ratio Rank: 99
Calmar Ratio Rank
XDG3.DE Martin Ratio Rank: 99
Martin Ratio Rank

CIB0.DE
CIB0.DE Risk / Return Rank: 22
Overall Rank
CIB0.DE Sharpe Ratio Rank: 33
Sharpe Ratio Rank
CIB0.DE Sortino Ratio Rank: 33
Sortino Ratio Rank
CIB0.DE Omega Ratio Rank: 33
Omega Ratio Rank
CIB0.DE Calmar Ratio Rank: 22
Calmar Ratio Rank
CIB0.DE Martin Ratio Rank: 00
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XDG3.DE vs. CIB0.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XDG3.DECIB0.DEDifference

Sharpe ratio

Return per unit of total volatility

-0.16

-0.56

+0.40

Sortino ratio

Return per unit of downside risk

-0.10

-0.68

+0.57

Omega ratio

Gain probability vs. loss probability

0.99

0.92

+0.07

Calmar ratio

Return relative to maximum drawdown

-0.12

-0.70

+0.58

Martin ratio

Return relative to average drawdown

-0.31

-1.80

+1.49

XDG3.DE vs. CIB0.DE - Sharpe Ratio Comparison

The current XDG3.DE Sharpe Ratio is -0.16, which is higher than the CIB0.DE Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of XDG3.DE and CIB0.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


XDG3.DECIB0.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.16

-0.56

+0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.24

-0.25

+0.49

Correlation

The correlation between XDG3.DE and CIB0.DE is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

XDG3.DE vs. CIB0.DE - Dividend Comparison

Neither XDG3.DE nor CIB0.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

XDG3.DE vs. CIB0.DE - Drawdown Comparison

The maximum XDG3.DE drawdown since its inception was -20.49%, smaller than the maximum CIB0.DE drawdown of -26.12%. Use the drawdown chart below to compare losses from any high point for XDG3.DE and CIB0.DE.


Loading graphics...

Drawdown Indicators


XDG3.DECIB0.DEDifference

Max Drawdown

Largest peak-to-trough decline

-20.49%

-26.12%

+5.63%

Max Drawdown (1Y)

Largest decline over 1 year

-13.54%

-15.52%

+1.98%

Current Drawdown

Current decline from peak

-9.38%

-24.58%

+15.20%

Average Drawdown

Average peak-to-trough decline

-5.17%

-9.86%

+4.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.70%

6.06%

-1.36%

Volatility

XDG3.DE vs. CIB0.DE - Volatility Comparison

The current volatility for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) is 4.27%, while VanEck Bionic Engineering UCITS ETF A (CIB0.DE) has a volatility of 5.01%. This indicates that XDG3.DE experiences smaller price fluctuations and is considered to be less risky than CIB0.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


XDG3.DECIB0.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.27%

5.01%

-0.74%

Volatility (6M)

Calculated over the trailing 6-month period

10.22%

12.42%

-2.20%

Volatility (1Y)

Calculated over the trailing 1-year period

16.97%

19.46%

-2.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.09%

17.80%

-4.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.09%

17.80%

-4.71%